
Sign up to save your podcasts
Or


Should zuranolone be a first-line treatment for postpartum depression? In this episode, Dr. Phelps discusses a randomized trial of zuranolone—a new neuromodulatory steroid—in the context of previous guidelines for the treatment of postpartum depression.
Faculty: Jim Phelps, M.D. Host: Jessica Diaz, M.D.
By Psychopharmacology Institute4.6
269269 ratings
Should zuranolone be a first-line treatment for postpartum depression? In this episode, Dr. Phelps discusses a randomized trial of zuranolone—a new neuromodulatory steroid—in the context of previous guidelines for the treatment of postpartum depression.
Faculty: Jim Phelps, M.D. Host: Jessica Diaz, M.D.

695 Listeners

76 Listeners

495 Listeners

146 Listeners

302 Listeners

3,342 Listeners

161 Listeners

1,353 Listeners

710 Listeners

557 Listeners

472 Listeners

369 Listeners

717 Listeners

191 Listeners

154 Listeners